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ABSTRACT We report on the ﬁrst, to our knowledge, successful detection of a ﬂuorescent unnatural amino acid (fUAA),
Lys(BODIPYFL), incorporated into a membrane protein (the muscle nicotinic acetylcholine receptor, nAChR) in a living cell. Xen-
opus oocytes were injected with a frameshift-suppressor tRNA, amino-acylated with Lys(BODIPYFL) and nAChR (a/b190GGGU/
g/d) mRNAs. We measured ﬂuorescence from oocytes expressing nAChR b190Lys(BODIPYFL), using time-resolved total inter-
nal reﬂection ﬂuorescence microscopy. Under conditions of relatively low receptor density (<0.1 receptors/mm2), we observed
puncta with diffraction-limited proﬁles that were consistent with the point-spread function of our microscope. Furthermore, diffrac-
tion-limited puncta displayed step decreases in ﬂuorescence intensity, consistent with single-molecule photobleaching. The
puncta densities agreed with macroscopic ACh-induced current densities, showing that the fUAA was incorporated, and that re-
ceptors were functional. Dose-response relations for the nAChR b190Lys(BODIPYFL) receptors were similar to those for wild-type
receptors. We also studied nAChR b190Lys(BODIPYFL) receptors labeled with a-bungarotoxin monoconjugated with Alexa488
(aBtxAlexa488). The nAChR has two aBtx binding sites, and puncta containing the Lys(BODIPYFL) labeled with aBtxAlexa488
yielded the expected three discrete photobleaching steps. We also performed positive control experiments with a nAChR
containing enhanced green ﬂuorescent protein in the g-subunit M3-M4 loop, which conﬁrmed our nAChR b190Lys(BODIPYFL)
measurements. Thus, we report on the cell-based single-molecule detection of nAChR b190Lys(BODIPYFL).INTRODUCTION
Fluorescent labeling of proteins is a valuable technique for
understanding biological processes at the cellular and subcel-
lular levels. In a widely used method with subcellular resolu-
tion, a fluorescent protein (FP) (Fig. 1 A) (1) is genetically
fused to a protein of interest (2,3). Such FP fusions are
used to measure protein expression levels, colocalization,
and trafficking. The FP moieties, however, are typically
~27 kDa, and therefore may interfere with protein function,
folding, and stability. Several methods were developed to
overcome these limitations. For example, fluorophores
with appropriate chemical groups can react with appropriate
amino-acid side chains, but such fluorophores label all
proteins in a nonselective manner in living cells (4,5). The
selective posttranslational labeling of proteins was achieved
by introducing unnatural amino acids that can then be deriv-
atized via bio-orthogonal reactions (6–8). However, these
reactions may not reach completion, and the reagents may
partition nonspecifically into membranes. Orthogonal enzy-
matic labeling approaches have expanded the toolkit for
protein labeling, but require the insertion of a peptide
sequence and subsequent labeling (9,10). Peptide sequences
with binding affinity or reactivity toward lanthanide ions
(11,12) and synthetic dyes (13) can also be encoded into
proteins and synthetic peptides. Nevertheless, the intracellu-
lar labeling of proteins remains challenging.
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0006-3495/09/01/0226/12 $2.00Fluorescent unnatural amino acids (fUAAs) represent an
attractive alternative strategy. Previously, fUAAs were in-
corporated into various types of proteins, using nonsense
(14–19) and frameshift (15,18) suppression methodologies.
Orthogonal tRNA/aminoacyl-tRNA synthetase pairs that
can incorporate fUAAs were also developed (20–22). Sev-
eral fUAAs were incorporated into functional proteins and
detected with conventional cuvette or gel-based fluorescence
measurements. Fluorescence moieties that were incorporated
include: 5-hydroxytryptophan (21), 7-azatryptophan (16),
dansyl (20), coumarin (23), NBD-Dap (14), Aladan (19),
and BODIPYFL derivatives (15,18). These fluorophores
span a wide spectral range, indicating the generality of non-
sense and frameshift-suppression methodologies for the
site-specific incorporation of fUAAs into proteins.
For example, fUAAs were previously incorporated into re-
ceptors and ion channels heterologously expressed in Xeno-
pus oocytes by nonsense suppression. The NBD-Dap and
Aladan were incorporated into the functional neurokinin-2
(NK2) receptor (14) and voltage-gated potassium channel
Kir2.1 (19), respectively. Plasma membranes from oocytes
were isolated, and the fluorescence of NBD-Dap incorporated
into the NK2 receptor was measured with cuvette fluores-
cence spectrometry. In addition, a NK2 cysteine mutant was
labeled with a tetramethylrhodamine (TMR) thiol-reactive
fluorescent probe, and Fo¨rster (or fluorescence) resonance en-
ergy transfer (FRET) was detected between the NBD donor
and TMR (14). However, to the best of our knowledge, there
are no reports of fluorescence imaging with fUAAs incorpo-
rated into membrane proteins in living cells. Live-cell fluores-
cence imaging is essential in understanding the fundamental
doi: 10.1016/j.bpj.2008.09.034
Single-Channel Imaging with Lys(BODIPYFL) 227FIGURE 1 Structure of molecules studied in these experiments. (A) Crystal structure of GFP, Protein Data Bank accession code 1EMA. (B) Structure of
Lys(BODIPYFL): same scale as GFP (bottom), and magnified (top). (C) Top view of Torpedo nAChR cryo-EM structure, Protein Data Bank accession
code 2BG9. Green residue with red-dashed circle indicates nAChR b190 site. (D) Side view of nAChR b-subunit, with 190 site indicated in green. (E) Structure
of BODIPYFL-C3-MTS.function and trafficking of ion-channel proteins. This is espe-
cially true of neuronal ion-channel proteins, whose function
(24) and expression patterns (25) have subcellular specificity.
To extend fUAA incorporation to living cells and also to
the single-molecule level, we chose an ion-channel molecule
that is well-characterized, but still poses important scientific
questions. We studied the incorporation of Lys(BODIPYFL)
(Fig. 1 B) into the mouse muscle nicotinic acetylcholine
receptor (nAChR) heterologously expressed in Xenopus
oocytes. The nAChRs are cation-selective, ligand-gated ion
channels (LGICs) in the pentameric Cys-loop superfamily.
Muscle nAChR has a subunit stoichiometry of 2a1/b1/d/g.
Each subunit contains an extracellular ligand-binding domain,
a transmembrane region with four a-helices (M1, M2, M3,
and M4), and a substantial intracellular region between the
M3 and M4 helices (Fig. 1 C–D) (26,27). The ACh binding
sites are at the a-g and a-d subunit interfaces. The transmem-
brane M2 a-helices from each subunit line the pore axis (28).
The M2 transmembrane regions of all LGICs are spanned by
>20 amino acids, whose sequence is often summarized ac-
cording to a numbering system (29) in which 00 is the most
intracellular, N-terminal position of the M2 helix. Despite
extensive structure-function studies on the conformational
changes that translate ligand-binding at the ACh binding
site into the opening of the gate ~60 A˚ away (30–33), the na-
ture and order of structural motions are still undetermined.
This lack of direct conformational measurements arises in
part because many residues in the M2 domain and other
‘‘buried’’ domains are at best partially accessible for post-
translational fluorescent labeling using conventional
methods such as cysteine reactions. Therefore, we incorpo-
rated the fUAA Lys(BODIPYFL) into the nAChR b-subunit
M2 domain 190 position (b190) (Fig. 1 D), a site that was par-
tially probed by fluorescence labeling (30). The nAChR b190
site is an important gating residue and a candidate for future
single-molecule FRET studies.
We used single-molecule total internal reflection fluores-
cence (TIRF) microscopy to measure fluorescent nAChRs.We studied the photobleaching of diffraction-limited puncta
to assess the incorporation of fUAA. We also compared
fluorescence signals from the nAChR b190Lys(BODIPYFL)
labeled with a second fluorophore, a-bungarotoxin mono-
conjugated with Alexa488 (aBtxAlexa488). We compared
signals from nAChR containing enhanced green fluorescent
protein in theg-subunitM3-M4 loop (geGFP)with our nAChR
b190Lys(BODIPYFL) observations. Fluorescence mea-
surements with nAChR b190C labeled with BODIPYFL-
C3-MTS (Fig. 1 E), a thiol-reactive BODIPYFL variant,
were not possible because BODIPYFL-C3-MTS does not
label the b190C residue. Thus, our study illustrates the advan-
tages and current limitations of biosynthetically incorporating
fUAAs into ion channels at buried residues.
METHODS
Reagents and materials
Preparation of a-NVOC-L-Lys(BODIPYFL)-O-dCA
All reagents were purchased from Sigma-Aldrich (St. Louis, Mo.) unless
otherwise noted. The high-performance liquid chromatography (HPLC)
instrumentation was described elsewhere (35). We prepared a-NVOC-L-
Lys(BODIPYFL)-OCH2CN using the protocol reported for a-NVOC-3-
(6-(biotinoyl)amino)hexanoyl-L-lysine cyanomethylester (35). Briefly,
3-Boc-L-Lys (100 mg, 0.41 mmol; Bachem, Torrance, CA), NVOC-Cl
(168 mg, 0.62 mmol), and Na2CO3 (65 mg, 0.62 mmol) were dissolved in
18 MU H2O/dioxane (1:1.4, 85 mL) and stirred at room temperature for 8
h. The presence of product was confirmed with APCI-MS: calculated for
C21H30N3O10
 484.19; found [M  H]: 484.1. Then, 15 mL of 1 M
NaHSO4 were added to the reaction, and a-NVOC-3-Boc-L-Lys was ex-
tracted with CH2Cl2 (30 mL  3). The CH2Cl2 fractions were combined
and removed by rotary evaporation. The sample was not further purified,
and a-NVOC-3-Boc-L-Lys (~19.8 mg, 0.04 mmol) was dissolved in
CH2Cl2 (3 mL). The TFA (3 mL) was added, and the mixture was stirred
at room temperature. The CH2Cl2 was added 30 min later, and the solvents
were removed with rotary evaporation. The a-NVOC-L-Lys was purified
with semipreparative HPLC, using a linear gradient of 100% 25 mM
NH4Ac buffer (pH 4.5) against the organic phase (98%/2% ACN/18 MU
H2O) for ~60 min. Fractions corresponding to the 350-nm absorption
peak from the NVOC group were pooled and lyophilized. The NVOC ab-
sorption extinction coefficient at 260 nm 3260 (2140 M
1 cm1) was used
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ence of a-NVOC-L-Lys was confirmed by positive mode atmospheric pres-
sure chemical pressure ionization mass spectrometry: calculated for
C16H24N3O8
þ 386.16; found [M þ H]þ: 386.1. Twelve milligrams of
a-NVOC-L-Lys and 5 mg of 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-
s-indacene-3-propionic acid, succinimidyl ester (BODIPY FL, SE, Invitro-
gen, Carlsbad, CA), were dissolved in 2 mL of dimethylformamide
(DMF) and 4.4 mL of diisopropylethylamine, and mixed for 7 h. An aqueous
workup was performed with 25 mL of 1 M NaHSO4, and the product was
extracted with CH2Cl2 (30 mL  3). The CH2Cl2 extractions were pooled
together and dried over Na2SO4 for 1 h. The CH2Cl2 was removed with ro-
tary evaporation. The DMF was removed by simultaneously immersing the
round-bottomed flask with the sample in a 60C water bath and attaching it
to a high vacuum line with solvent traps. Next, the sample was mixed with
42 mL of ClCH2CN, 3 mL of triethylamine, and 1 mL of DMF. The reaction
was allowed to proceed for ~7 h before an aqueous workup was performed
with 15 mL of NaHCO3 and CH2Cl2 (25 mL  3). The organic phase was
dried over Na2SO4 for 30 min, and the CH2Cl2 was removed with rotary
evaporation. The product was purified with semipreparative HPLC, using
a linear gradient of 100% 25 mMNH4Ac buffer (pH 4.5) against the organic
phase (98%/2% ACN/18 MU H2O) for ~60 min. The fractions that had both
absorbance peaks of the NVOC (~350 nm) and BOPIDYFL (~504 nm) and
identical elution times were collected, pooled, and lyophilized. The product
yield was 6.8 mg (76% yield). The sample was identified by positive mode
electrospray ionization mass spectrometry: calculated for C32H38BF2N6O9
þ
699.28; found [M þ H]þ: 699.2, and the solvent was lyophilized. The 1H
NMR (300 MHz, CD3CN) d 7.70 (s, 1H), 7.36 (s, 1H), 7.13 (s, 1H), 7.00
(d, 1H), 6.44 (m, 2H), 6.31 (d, 1H), 6.23 (s, 1H), 5.43 (m, 2H), 4.82 (s,
2H), 4.24 (m, 1H), 3.95 (s, 3H), 3.89 (s, 3H), 3.15 (m, 4H), 2.53 (m, 2H),
2.27 (s, 3H), 2.17 (m, 3H), 1.8 (m, 2H), and 1.42 (m, 4H).
The a-NVOC-L-Lys(BODIPYFL)-O-CH2CN and dCA were dissolved in
1 mL of DMF and stirred under argon (Ar) for ~24 h (in vacuo). The
presence of sample was confirmed with analytical HPLC. Preparative
HPLC was used to purify a-NVOC-L-Lys(BODIPYFL)-O-dCA, and nega-
tive mode electrospray ionization mass spectrometry: calculated for
C49H59BF2N13O21P2
 1,276.35; found [M  H]: 1276.4 confirmed the
presence of product from the fractions that contained absorption peaks at
350 and 505 nm. The product yield was 36.1 mg (1.6% yield), based on
the BODIPYFL absorption 504-nm absorption peak and an extinction coef-
ficient of 3504 (80,000 M
1cm1) (36).
Preparation of BODIPYFL-C3-MTS
Twelve milligrams of 3-aminopropyl methanethiosulfonate hydrobromide
(Toronto Research Chemicals, Toronto, Ontario, Canada) and 250 mg of
4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionic acid,
succinimidyl ester (BODIPY FL, SE, Invitrogen), were dissolved in 1 mL
of DMF and 10 mL of diisopropylethylamine and mixed for 1.5 h. The prod-
uct was purified with semipreparative HPLC, using a linear gradient of aque-
ous phase (2%/98% ACN/18 MU H2O) against the organic phase (98%/2%
ACN/18 MU H2O) for ~30 min. The fractions that had the BOPIDYFL
(~504 nm) absorbance peak were collected, pooled, and lyophilized. The sam-
ple was then identified by positive mode electrospray ionization mass spec-
trometry: calculated for [M þ K]þ 482.13; found [M þ K]þ: 482.0, and
the solvent was lyophilized. The product yield was determined to be 324
mg (57% yield), based on the BODIPYFL absorption 504-nm absorption
peak and extinction coefficient of 3504 (80,000 M
1cm1) (36).
Preparation of YFaFSACCC-a-NVOC-L-Lys(BODIPYFL)
The YFaFSACCC tRNA was prepared by linearization of pUC19 containing
the YFaFSACCC gene with Fok1, which yields 74mer-tRNA upon in vitro
transcription with the MegaShortScript kit (Ambion, Austin, TX) (37).
The dCA-a-NVOC-L-Lys(BODIPYFL) was ligated to the 74mer-YFaF-
SACCC with T4 RNA ligase, which yielded YFaFSACCC-a-NVOC-L-
Lys(BODIPYFL) as previously described (38–40). The product was desalted
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View, CA). The presence of product was confirmed with ultraviolet absorp-
tion at 260 nm and matrix assisted laser desorption ionization mass
spectrometry. The major peak indicated that YFaFSACCC-a-NVOC-L-
Lys(BODIPYFL) was the principal product of the ligation reaction.
Construct preparation and mRNA transcription
The mouse muscle nAChR subunits (a, g, and d) are in the pAMV vector.
The b190GGGU construct was prepared by QuikChange (Stratagene, La
Jolla, CA) mutagenesis on the masked b-subunit in the pAMV vector
(37). The mutation was verified by sequencing (California Institute of Tech-
nology Sequencing/Structure Analysis Facility). The mRNAs were prepared
from NotI linearized plasmid DNA, using a T7 mMessage mMachine kit
(Ambion), and were purified with the RNeasy Mini kit (Qiagen, Valencia,
CA). Concentration was determined by absorption at 260 nm.
The geGFP construction was prepared as follows. The eGFP insertion in
the g-M3-M4 cytoplasmic domain has no effect on the electrophysiological
properties of nicotinic receptors (abgeGFPd) (41). Therefore, we inserted
eGFP after position S380 in the g-M3-M4 cytoplasmic loop by polymerase
chain reaction. The construct was synthesized from three segments by poly-
merase chain reaction. Primers to amplify the first segment are geGFP - For-
ward No. 1 (ACC ATG GCA CAA GGG GGC CAG AGA CCT CAT CTC
CTC TTG CTG, where ATG is the initiation codon of the g-subunit); geGFP
-Reverse No. 1 (50- CAG CTC CTC GCC CTT GCT CAC CAT TGA
GGA AGA GCC ATT CTG GAG TCG-30; bold sequences represent the
N-terminal of eGFP). The second segment was synthesized by geGFP -For-
ward No. 2 (50- CGA CTC CAG AAT GGC TCT TCC TCA ATG GTG
AGC AAGGGCGAGGAGCTG -30; bold sequences represent the N-ter-
minus of the eGFP) and geGFP -Reverse No. 2 (5
0- CTC TCG AGC CAT
GAT GGG CCA CCC CTT GTA CAG CTC GTC CAT GCC GAG -30;
bold sequences represent the C-terminus of eGFP). The third segment was
synthesized by the following geGFP -Forward No. 3 (5
0- CTC GGC ATG
GAC GAG CTG TAC AAG GGG TGG CCC ATC ATG GCT CGA
GAG -30; bold sequences represent the C-terminus of the eGFP) and geGFP
-Reverse No. 3 (50- GTC GAC TCA GTC TGG CAA AGG CAG GTA
GGG GCG GGGGTC TCC -30; bold TCA represents the termination codon
of the g-subunit). Finally, the entire construct was amplified from all three
segments, using geGFP -Forward No. 1 and geGFP -Reverse No. 3, and was
subcloned into the pAMV vector. The entire construct was verified by
DNA sequencing (Davis Sequencing, Davis, CA).
Oocyte preparation, injection, and aBtxAlexa488
labeling
Stage VI oocytes fromXenopus laeviswere isolated and maintained at 16C in
ND96 solution consisting of 96 mMNaCl, 2 mMKCl, 1 mMMgCl2, 1.8 mM
CaCl2, and 5 mM HEPES (pH 7.5), supplemented with Na pyruvate (2.5
mM), gentamycin (50 mg/mL), theophylline (0.6 mM), and horse serum
(5%). Before injection, YFaFSACCC-a-NVOC-L-Lys(BODIPYFL) was
irradiated at 350 nm to cleave the NVOC group, yielding the deprotected
tRNA-fUAA (YFaFSACCC-Lys(BODIPYFL)). Then the YFaFSACCC-Lys
(BODIPYFL) was kept at 4C until mixing with the mRNA and loaded for
oocyte injection. Each oocyte was injected with a 1:1 volume mixture of
YFaFSACCC-Lys(BODIPYFL) (12.5 or 25 ng) and mRNA (25 ng of total con-
centration ratio of 2:5:1:1 for a/b190GGGU/g/d subunits) in a 50-nL volume.
Wild-type (WT) nAChR a, b, and d and either WT g or geGFP mRNA were
mixed at a ratio of 2:1:1:1 and diluted to a final concentration of 1 ng/25 nL.
Oocytes were labeled with a-bungarotoxin conjugated to Alexa Fluor 488
(aBtxAlexa488) (Invitrogen), dissolved in ND96. We experimented with
various labeling concentrations and incubation times, and determined that
incubating oocytes with 20–40 nM aBtxAlexa488 for 8–12 h resulted in
optimal labeling. The incubations were terminated by transferring oocytes
to a 5 mg/mL bovine serum albumin solution, followed by two ~30-min
washes in ND96 before imaging. The manufacturer furnished aBtxAlexa488
at a nominal concentration of 1mg/mL.We determined themolar ratio of aBtx
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8600 (aBtx MW ¼ 7966.23 Da, Alexa Fluor 488 carboxylic acid ¼ 532.5
Da, and linkerMW¼unknown, assumed to be 100Da), theAlexa488 absorp-
tion peak at 488 nm, the extinction coefficient of 65,000 M1cm1 (36), and
the NanoDrop (Thermo Scientific, Wilmington, DE) A280 protein assay. The
molar ratio of aBtx/Alexa488 was 1:0.74. The attempted labeling of the
nAChR b190C receptor with 5 nM and 5 mMBODIPYFL-C3-MTS was per-
formed as previously reported (30).
Electrophysiology
A two-electrode voltage clamp was used to record currents from oocytes.
Recordings were performed 24–48 h after injection with a GeneClamp
500 amplifier (Axon Instruments, Union City, CA). The pipette microelec-
trodes were filled with 3 M KCl, and had resistances ranging from 0.5–2
MU. Oocytes were perfused continuously with a calcium-free solution con-
taining 96 mMNaCl, 2 mMKCl, 1 mMMgCl2, and 5 mMHEPES (pH 7.5).
The ACh-induced currents were recorded in response to a series of ACh
applications (1–1000 mM).
Total internal reﬂection ﬂuorescence microscopy
Xenopus oocytes were prepared for single-molecule TIRF microscopy as
follows. The oocytes were transferred to a petri dish filled with hypertonic
solution (220 mM Na aspartate, 10 mM EDTA, 2 mM MgCl2, and 10 mM
HEPES, pH 7.4) and incubated for 5–10 min. The vitelline membrane was
removed with forceps, under a dissecting microscope. Oocytes were trans-
ferred to an imaging chamber mounted on the microscope stage. The imag-
ing chamber bottom had a glass coverslip that was cleaned with one of two
protocols. The first protocol consisted of rinsing with 90% EtOH and 18 MU
water. Alternatively, they were immersed in a solution composed of (v/v)
90% 18 MU water/7% H2SO4/3% H2O2. The oocyte was positioned with
the animal pole oriented toward the coverslip. The vegetal pole was not used
because of a high autofluorescence background. Experiments were per-
formed at 18–20C, to minimize sample drift and maximize the amount of
time the oocytes remained mechanically stable. Before imaging, we allowed
oocytes to incubate in the imaging chamber for ~10 min, to maximize adher-
ence. Next, transmitted bright-field illumination was used to confirm oocyte
adherence, using coarse focus. Oocytes typically adhered over a circular area
R200 mm in diameter. A region of interest was selected to focus and establish
the TIRF condition, using laser excitation (<140 mW/cm2). An adjacent area
was used to conduct measurements, so as to limit unintended photobleaching
during fine focus. In experiments where macroscopic experiments show ad-
equate expression, nearly all injected oocytes yield TIRF images with clearly
isolated puncta. The most informative data are generated from images whose
puncta density is in the measurable range, i.e., 0.001–0.06/mm2. Anomalously
high backgrounds are found in the <5% of oocytes that collapse and tear in
the imaging chamber. These oocytes were most likely damaged during vitel-
line membrane removal, and are excluded from analysis. The TIRF micro-
scope for collecting images consists of a Melles-Griot Ar ion laser (CVI
Melles Griot, Carlsbad, CA) coupled to a fiber optic that extended to an
Olympus TIRF illuminator adapted to an IX-71 Olympus inverted micro-
scope (Center Valley, PA). The Ar laser emits three wavelengths: at 457
nm (~2 mW), 488 nm (~15.6 mW), and 514 nm (~10 mW). We selected
the 488-nm wavelength, required to excite and detect Lys(BODIPYFL),
geGFP, and aBtxAlexa488, using the Z488 filter cube (Chroma Technology
Corp., Rockingham, VT). The unfiltered maximum power at the objective
entrance was 4.4 mW (~140 mW/cm2). Where appropriate, neutral density
filters were used to reduce power by up to threefold during imaging. The in-
tegration time was 0.5 s for all images. A 100 1.45-NA TIRF objective
(Olympus) was used. Time-lapse images were captured with a Photometrics
Cascade 650 front-illuminated CCD camera (Princeton Instruments, Trenton,
NJ). The frame area at100 magnification is 48.3 36.4 mm¼ 1728.1 mm2.
Slidebook (Intelligent Imaging Innovations, Inc., Santa Monica, CA) was
used to acquire data. The data were subsequently processed and analyzed
with ImageJ (National Institutes of Health, Bethesda, MD) (42), Clampfit9.2 (Axon Instruments, Foster City, CA), Origin 7.0 (OriginLab, Northamp-
ton, MA), and MatLab R2006a (The MathWorks, Inc., Natick, MA).
Image analysis
The images acquired with Slidebook were exported as 16-bit time series
stack files in TIFF format. The ImageJ (National Institutes of Health) region
of interest (ROI) manager was used to document the puncta in the first frame
of time stacks. Rectangular 15 15 pixel ROIs, centered on a putative single
punctum, were duplicated and batch-processed using MatLab R2006a. The
point-spread function (PSF) of individual puncta were fit to a two-dimen-
sional Gaussian function:
PSF

x; y; xc; yc; Sx; Sy;A;B
 ¼ B þ A exp
h
 ðx  xcÞ
2
2S2x
 ðy  ycÞ
2
2S2y
i
;
(1)
where (xc, yc) is the centroid of the punctum, Sx and Sy are the respective
standard deviations along the x axis and y axis, A is the amplitude, and B
is the baseline. Next, the full width at half-maximum (FWHMx,y) along
the x and y axes were determined, FWHMi ¼ 2 ð
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
lnð4Þp Þ  Si, and
compared against the FWHMtheoretical PSF of the microscope, which is
approximated by the equation (43,44):
FWHMtheoreticalz
0:55  lemission
NA
; (2)
where lemission is the emission peak of the fluorescent molecule, andNA is the
numerical aperture of the objective (NA ¼ 1.45). The PSF is deformed by
several factors, including spherical aberrations, excitation-field nonunifor-
mity (45,46), pixel nonuniformity, background nonuniformity (45), and
others. Demuro and Parker reported that muscle nAChRs undergo lateral
motions of5<50 nm on a time scale of ~10 s (47). Therefore, puncta with
FWHMx,y ¼ 1955 74.5 nm (or 2.915 1 pixels) were classified as diffrac-
tion-limited, immobile spots, and were selected for puncta density and photo-
bleaching analysis. Time-lapse images with minimal lateral and vertical drift
were selected for photobleaching step analysis. The peak pixel value against
time was plotted for ROIs with puncta that fulfilled the stated FWHMx,y
criteria. Time-lapse traces were imported into Clampfit and analyzed.
RESULTS
In the nonsense and frameshift-suppression methodologies
for site-specific UAA incorporation, the chemically amino-
acylated tRNA is a stoichiometric reagent that limits the
number of functional channels that can be expressed (48).
This low expression level is well-suited to the sensitivity
of electrophysiology. Here we demonstrate that single-mole-
cule TIRF microscopy complements the sensitivity of elec-
trophysiology. TIRF microscopy excites only molecules
that are within ~100 nm of the glass surface, thereby mini-
mizing interference from cytoplasmic autofluorescence, in-
cluding unincorporated fUAAs (tRNA-fUAA or free fUAA).
Thus, TIRF microscopy, integrated with a CCD camera with
single-molecule sensitivity, enables the optical detection of
ion channels expressed at the plasma membrane in low num-
bers (< 0.015/mm2).
tRNA-fUAA and heterologous expression
in Xenopus oocytes
Based on previous cell-free synthesis applications (15,49,50)
and photophysical properties, i.e., favorable absorption coef-
ficient (3, ~80,000–91,000 M1 cm1) and quantum yieldBiophysical Journal 96(1) 226–237
230 Pantoja et al.approaching 1.0 (15,36), Lys(BODIPYFL) (Fig. 1 B) was se-
lected as the fUAA for incorporation into nAChR. The single
amino-acid substitution of Lys(BODIPYFL) (Fig. 1 B) is pre-
sumably less perturbing than substituting eGFP (Fig. 1A) into
the transmembrane a-helix (Fig. 1 D). For fUAA incorpora-
tion, we chose to use the yeast Phe frameshift-suppressor
(YFaFSACCC) that recognizes the quadruplet codon GGGU
and contains seven mutations in the acceptor stem (denoted
by lower-case ‘‘a’’) to avoid recognition by endogenous ami-
noacyl-tRNA synthetases (aaRSs). The YFaFSACCC is recog-
nized least by the endogenous aaRSs of any suppressor tRNA
screened in our laboratories, and therefore should not incorpo-
rate natural amino acids at the suppression site (37,51,52). As
described in Methods, we first synthesized dCA-Lys(BODI-
PYFL), the fUAA chemically amino-acylated on the
dinucleotide deoxyCA, and then enzymatically ligated
dCA-Lys(BODIPYFL) to the frameshift-suppressor tRNA
lacking the terminal CA nucleotides (74mer-YFaFSACCC),
which yielded YFaFSACCC-Lys(BODIPYFL), the full-length
76mer-tRNA ligated to the fUAA. The YFaFSACCC-Lys
(BODIPYFL) was mixed with nAChR a/b190GGGU/g/d
mRNA and injected into Xenopus oocytes. After incubation
for 1–2 days, the presence of nAChR b190Lys(BODIPYFL)
on the plasma membrane was confirmed with two-electrode
voltage-clamp electrophysiology (currents for a series of 5-s
ACh applications are shown in Fig. 2 A). The average maxi-
mal currents evoked by 1 mM ACh (Imax) were 6.3 5 0.6
mA (n¼ 5 oocytes) and 3.55 0.2 mA (n¼ 4 oocytes) for oo-
cytes injected with 25 and 12.5 ng YFaFSACCC-Lys(BODI-
PYFL), respectively. The ACh dose-response relationships
were generated for nAChR b190Lys(BODIPYFL) and WT
nAChR. The measured EC50 values were 385 2 and 605
4 mMACh, respectively, and the Hill coefficients were 1.15
0.05 and 1.3 5 0.01, respectively (n ¼ 5 and 9 oocytes,
respectively) (Fig. 2 B). Substantially smaller currents were
detected from oocytes injected with nAChR b190GGGU
mRNAonly (Imax¼ 0.785 0.5mA; n¼ 3 oocytes) or nAChR
b190GGGU mRNA with 74mer-YFaFSACCC (Imax ¼ 1.15
0.3 mA; n ¼ 3 oocytes) (Fig. 2 C).Single-molecule TIRF microscopy of an
incorporated fUAA
Single-molecule TIRF microscopy was used to detect the
presence of nAChR b190Lys(BODIPYFL) in the plasma
membrane (Fig. 3, A and B). Sparse fluorescent puncta
(<0.10 puncta/mm2) were detected 24 h after coinjection of
YFaFSACCC-Lys(BODIPYFL) (12.5 ng/oocyte) with
nAChR b190GGGU mRNA (25 ng/oocyte; n ¼ 5 oocytes;
Fig. 3 A and Fig. S1 A in the Supplementary Material). Con-
trol oocytes from the same batch were always injected with
YFaFSACCC-Lys(BODIPYFL), (i.e., with tRNA-fUAA, but
no mRNA), and sparse puncta were detected at lower levels
(< 0.015 puncta/mm2) (Fig. S1 B). The PSF of emission pro-
files (Fig. 3 B) of fluorescent single molecules were fitted to
a two-dimensional Gaussian function (45,53) (Fig. 3 C). We
compared the two-dimensional Gaussian FWHMx,y along the
x and y axes against the theoretical FWHM. The emission
peak of BODIPYFL is ~515 nm (36). Therefore, we defined
puncta with a FWHMx,y ¼ 195 5 74.5 nm (1 pixel) as dif-
fraction-limited spots for further analysis. Twenty percent
to 50% of all puncta detected were diffraction-limited re-
gions, consistent with the PSF of the TIRF microscope.
Time-series traces with single-molecule photobleaching
events were observed from puncta with diffraction-limited
regions (Fig. 3 D). Time-series imaging experiments demon-
strated that the puncta originated from one (80%), two
(17%), or three (3%) molecules (n ¼ 3 oocytes, 151 puncta),
as determined by discrete photobleaching events. Thus, al-
though the majority of puncta represented a single molecule,
a subset represented more than one molecule per diffraction-
limited spot.
To verify our observations with nAChR b190Lys
(BODIPYFL), we synthesized a thiol-reactive BODIPYFL
derivative, BODIPYFL-C3-MTS (Fig. 1 E). The nAChR
b190C was previously labeled with sulforhodamine-MTS
(MTSR), and voltage-clamp fluorometry was performed
(30). Thus, we experimented with labeling nAChR b190C
with BODIPYFL-C3-MTS, to compare the two labelingFIGURE 2 Electrophysiological properties of oocytes
expressing nAChR b190Lys(BODIPYFL). (A) Representa-
tive ACh-induced currents during a dose-response series,
in an oocyte expressing nAChR b190Lys(BODIPYFL) re-
ceptor. Each ACh application lasted 5 s. (B) Dose-response
curve for nAChR b190Lys(BODIPYFL) (open circles),
compared with WT data (solid circles). Error bars are
mean 5 SE (n ¼ 5 oocytes). Smooth curves represent a
fitted single-component dose-response relationship for
nAChR b190Lys(BODIPYFL) (EC50, 38 5 2 mM; Hill
coefficient, 1.15 0.05) and WT (EC50, 605 4 mM; Hill
coefficient, 1.3 5 0.01). (C) Average current induced
by 1- mM ACh application in oocytes injected with 25 ng
of a/b190GGGU/g/d mRNA þ 25 ng YFaFSACCC-
Lys(BODIPYFL) (mRNA þ tRNA-fUAA), 25 ng a/
b190GGGU/g/d mRNA only (mRNA), and 25 ng a/
b190GGGU/g/d mRNA þ 25 ng 74mer-YFaFSACCC
(mRNA þ 74mer-tRNA).
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Single-Channel Imaging with Lys(BODIPYFL) 231FIGURE 3 TIRF microscopy images of a representative oocyte expressing nAChR b190Lys(BODIPYFL). (A) An oocyte injected with nAChR
a/b190GGGU/g/d mRNA and YFaFSACCC-Lys(BODIPYFL). Scale bar represents 12 mm. The counts calibration bar with linear dynamic range is selected
for best display. The square is a representative punctum selected for presentation. (B) Representative punctum in 15 15 pixel region corresponding to square
in A. Scale bar represents 10 pixels, or 0.74 mm. (C) Two-dimensional Gaussian fit of punctum in B. (D) Single-molecule time-series photobleaching trace from
selected punctum.strategies directly. However, the TIRF microscopy images
show no difference between uninjected oocytes and those ex-
pressing nAChR b190C labeled with BODIPYFL-C3-MTS.
This observation agrees with reports that nAChR b190C is
primarily accessible to positively charged thiol-reactive
probes (54).
Ulbrich and Isacoff demonstrated the power of counting
ion-channel subunits by using genetically fused fluorescent
proteins (55). Therefore, we evaluated an alternative strat-
egy, which consisted of generating a nAChR mutant with
genetically fused eGFP. Previous data indicated that func-
tion and trafficking are well-preserved when FPs are incor-
porated into the M3-M4 intracellular loop of muscle (and
neuronal a4b2) nicotinic receptors (41,56,57). Thus, a
nAChR g-subunit construct with eGFP inserted in the
M3-M4 loop (nAChR geGFP) served as a positive control
for our observations with nAChR b190Lys(BODIPYFL).
The nAChR geGFP receptors were heterologously expressed
in oocytes at similar levels as in nAChR b190Lys
(BODIPYFL), and diffraction-limited puncta were detected
(Fig. 4 A and Fig. S1 C). Puncta from uninjected oocytes
were essentially nonexistent (Fig. S1 D). The nAChR geGFP
puncta consisted of ~1 (80%) (Fig. 4 B) and 2 (20%) photo-
bleaching steps (n ¼ 3 oocytes, 179 puncta), i.e., similar to
nAChR b190Lys(BODIPYFL). The amplitudes obtained
from the Gaussian fits of individual puncta from nAChR
b19’Lys(BODIPYFL) and nAChR geGFP at a similar exci-
tation power density (133 mW/cm2) were compared. The
nAChR b190Lys(BODIPYFL) and nAChR geGFP displayed
log-normal distributions (58), with a peak value at 1064
counts and log standard deviation (log SD) of 0.43 (n ¼
3 oocytes, 135 puncta), and a peak value at 501 counts with
a log SD of 0.51 (n ¼ 2 oocytes, 78 puncta), respectively
(Fig. 5).nAChR ﬂuorescent ligand conﬁrms the presence
of nAChR b190Lys(BODIPYFL) and nAChR geGFP
To gain confidence that the puncta originated from nAChR
b190Lys(BODIPYFL) and nAChR geGFP receptors, we
FIGURE 4 TIRF microscopy images of representative oocyte expressing
nAChR geGFP. (A) An oocyte injected with nAChR geGFP. Scale bar repre-
sents 12 mm. The counts calibration bar with linear dynamic range is selected
for best display. (B) Representative single-molecule time-series trace from
selected punctum.
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a-bungarotoxin monoconjugated to Alexa488 (aBtxA-
lexa488). Two aBtx molecules bind each muscle nAChR
irreversibly (59) on the time scale of interest in this study.
Thus, time-series traces with three photobleaching events
were expected when we labeled nAChR b190Lys
(BODIPYFL) and nAChR geGFP. First, WT nAChRs were
used to determine the aBtxAlexa488 baseline level of
labeling and the photobleaching step distribution. The WT
nAChR was expressed at similar levels as nAChR b190Lys
(BODIPYFL), as confirmed by ACh-induced currents
(Imax¼ ~2 mA). TheWT nAChR labeled with aBtxAlexa488
displayed puncta (Fig. S2 A) with a log-normal amplitude
distribution with a peak value at 773 counts and a log SD of
0.45 (n ¼ 2 oocytes, 149 puncta; 43 mW/cm2), and the peak
value increased to 1157 counts with a log SD of 0.43 at a
higher power density (n ¼ 1 oocyte; 102 puncta; 69 mW/
cm2) (Fig. 6 A). All photobleaching step analysis was re-
stricted to a relatively low power density of 43 mW/cm2,
to resolve multiple steps before photobleaching. The WT
nAChR labeled with aBtxAlexa488 resulted in 1 (48% 5
2%), 2 (43%5 3%), 3 (6%5 1%), and 4 (3%5 1%) de-
tected photobleaching steps (n ¼ 2 oocytes, 144 puncta)
(Fig. 6 B). Despite the two aBtx sites per receptor, WT recep-
tors labeled with aBtxAlexa488 displayed a plurality (~48%)
of single bleach steps under all conditions. We ascribe this
result to the incomplete labeling of aBtxAlexa488 (~74%
of aBtx are labeled by a fluorescent Alexa488; see Methods)
and to the unintentional photobleaching of fluorescent mole-
cules during sample-handling and a brief fine focus before
image acquisition. Thus, if (1), ~20% of puncta contain two
receptors and 80% contain one receptor, as based on results
from nAChR b190Lys(BODIPYFL) and nAChR geGFP, and
(2), 74% of the aBtx have a fluorescent Alexa488, then the
theoretical binomial fluorescent dye distribution per puncta
is: 0 (6%), 1 (32%), 2 (48%), 3 (8%), and 4 (6%). Excluding
FIGURE 5 Histograms of puncta amplitudes from oocytes expressing
either nAChR geGFP (black bars) or nAChR b19
0Lys(BODIPYFL) (gray
bars), using similar imaging conditions. The nAChR b190Lys(BODIPYFL)
and nAChR geGFP displayed log-normal distributions with a peak value at
1064 counts and a log SD of 0.43 (n ¼ 3 oocytes, 135 puncta), and
a peak value at 501 counts and a log SD of 0.51 (n ¼ 2 oocytes, 78 puncta),
respectively.
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ical photobleaching step distribution becomes 1 (34%), 2
(51%), 3 (9%), and 4 (6%). However, Alexa488 photo-
bleaches during fine focus. The measured photobleaching
step distribution is adequately explained by assuming that
the original 74% of fluorescent aBtx molecules decreased
to 57%: the theoretical observable distribution becomes 1
(49%), 2 (41%), 3 (8%), and 4 (2%). We use the following
assumptions throughout our step photobleaching analysis:
20% of diffraction-limited puncta contain two nAChRs, and
57% of the aBtx contain fluorescent Alexa488.
The nAChR geGFP were labeled with aBtxAlexa488
(Fig. 7 A and Fig. S2 B), and we detected a distribution of
1 (40% 5 3%), 2 (33% 5 2%), 3 (18% 5 3%), and R4
(9% 5 3%) photobleaching steps (n ¼ 2 oocytes, 148
puncta) (Fig. 7 B). Interestingly, the puncta density ratio be-
tween the nAChR geGFP receptors and the receptors labeled
with aBtxAlexa488 was 0.33 (n ¼ 4; two oocyte batches).
The apparent underreporting by the geGFP label, compared
with aBtxAlexa488, arises from at least two factors. The first
is unintended photobleaching during fine focus: eGFP
FIGURE 6 TIRF microscopy of oocyte expressing WT nAChR labeled
with aBtxAlexa488. (A) WT nAChRs labeled with aBtxAlexa488. Repre-
sentative puncta in boxed squares correspond to one and two photobleaching
steps. Scale bar equals 12 mm. (B) Representative traces, with one and two
photobleaching steps. Dashed guidelines indicate fluorescence levels.
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<100% of eGFP molecules reach the mature fluorescent
state (2). Again, if we assume that aBtxAlexa488 is report-
ing the presence of only 57% of receptors, then the expected
binomial distribution for photobleaching steps is: 1 (36%), 2
(41%), 3 (15%), and 4–6 (8%).
As expected, a subset of puncta containing the nAChR
b190Lys(BODIPYFL) labeled with aBtxAlexa488 yielded
three discrete photobleaching steps, in agreement with the
predicted stoichiometry (Fig. 8, A and B, and Fig. S2 C).
The oocytes injected with nAChR b190GGGU mRNA and
YFaFSACCC-Lys(BODIPYFL), and incubated with aBtx-
Alexa488, displayed puncta with 1 (44%5 8%), 2 (36%5
2%), 3 (18% 5 8%), and 4–6 (2% 5 1%) photobleach-
ing steps (n ¼ 3 oocytes, 194 puncta). The puncta density
ratio between nAChR b190Lys(BODIPYFL) and nAChR
b190Lys(BODIPYFL) labeled with aBtxAlexa488 was
0.47. If the probability of a punctum having one detectable
Lys(BODIPYFL) per nAChR is 47%, then the binomial dis-
tribution for measurable photobleaching steps is: 1 (31%), 2
(41%), 3 (19%), and 4–6 (9%). Thus, the measured photo-
FIGURE 7 TIRF microscopy of oocyte expressing nAChR geGFP labeled
with aBtxAlexa488. (A) nAChR geGFP labeled with aBtxAlexa488. Puncta
in boxes are diffraction-limited spots with 1, 2, and 3 photobleaching steps.
Scale bar represents 12 mm. The intensity calibration bar with linear dynamic
range is selected for best display. (B) Representative traces with 1, 2, and 3
photobleaching steps. Dashed guidelines indicate fluorescence levels.bleaching-step percentages are within ~13% of values ex-
pected from straightforward molecular labeling (Fig. 9 A).
Fluorescent puncta density and current density
analysis
We observed that the optimal single-molecule TIRF micros-
copy range was Imax ¼ 1–5 mA for WT nAChRs (subse-
quently labeled with aBtxAlexa488) and for nAChR geGFP.
In oocytes with ACh-induced currents <1 mA, no nAChR
geGFP receptors were detected. Thus, we compared puncta
density with recorded currents. We made the following as-
sumptions: 1), The nAChRs were distributed homogenously
throughout the oocyte plasma membrane. 2), The oocyte
plasma membrane uniformly adhered to the glass coverslip
during single-molecule TIRF imaging, so that the measured
image frames can be extrapolated to the entire oocyte. 3),
Stage VI Xenopus oocyte plasma membrane capacitance is
0.25 mF (reported range, 0.19–0.25 mF) (60,61). 4), The spe-
cific membrane capacitance is 0.8 mF/cm2 (62), implying that
FIGURE 8 TIRF microscopy of an oocyte expressing nAChR
b190Lys(BODIPYFL) labeled with aBtxAlexa488. (A) TIRF image of an
oocyte expressing nAChR b190Lys(BODIPYFL) receptors labeled with
aBtxAlexa488. Puncta in boxes are diffraction-limited spots with 1, 2,
and 3 photobleaching steps. Scale bar represents 12 mm. The intensity cali-
bration bar with linear dynamic range selected for best display. (B) Repre-
sentative traces with 1, 2, and 3 photobleaching steps, corresponding to
puncta in squares. Dashed guidelines indicate fluorescence levels.
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mm2. 5), Desensitization was negligible during the growth
phase of ACh-induced currents, so that Imax measures the
simultaneous activation of all receptors. 6), Receptors in
microvilli that contribute to capacitance measurements are
retained during imaging (63). Additional experimental de-
tails were as follows: 7), The image frame area was 1758.1
mm2. 8), The oocyte holding potential was 60 mV. 9),
FIGURE 9 Summary of photobleaching steps and puncta-density
statistics. (A) Percent of puncta versus number of photobleaching steps mea-
sured for oocytes with surface-expressed WT nAChRs, nAChR
b190Lys(BODIPYFL), and nAChR geGFP labeled with aBtxAlexa488,
and imaged under similar conditions. Error bars report the mean 5 SE.
(B) Average puncta density for oocytes expressing nAChR
b190Lys(BODIPYFL) (b190Lys(BODIPYFL)), nAChR geGFP (geGFP), WT
nAChR (WT), YFaFSACCC-Lys(BODIPYFL) (tRNA-fUAA), and unin-
jected (UI) oocytes with and without aBtxAlexa488 labeling. The puncta
density predicted from current density is plotted for nAChR
b190Lys(BODIPYFL), nAChR geGFP, and WT nAChR oocytes. Dashed
line represents correspondence between puncta density of 0.019/mm2
and expected current of 1 mA. Error bars report mean5 SE.
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channel nAChR conductance was 36 pS (64).
In experiments onWT nAChRs, Imax¼ 1.45 0.5 mA, im-
plying an expected density of 0.027 receptors/mm2. When
these oocytes were labeled with aBtxAlexa488, we mea-
sured 0.036 5 0.01 puncta/mm2 (range, 0.017–0.058/mm2;
n ¼ 3 oocytes) (Fig. 9 B).
In experiments with nAChR geGFP, Imax ¼ 1.55 0.8 mA,
leading to an expected receptor density of 0.029/mm2. The
measured puncta density was 0.020 5 0.006/mm2 (range,
0.013–0.032/mm2; n ¼ 3 oocytes) (Fig. 9 B). Other oocytes
from this nAChR geGFP batch were also labeled with aBtx-
Alexa488. The measured puncta density for nAChR geGFP
labeled with aBtxAlexa488 was 0.059 5 0.03/mm2 (range,
0.018–0.126/mm2; n¼ 3 oocytes) (Fig. 9 B). Puncta with sin-
gle-molecule profiles were observed at a lower density for
relevant control oocytes: the measured puncta density for un-
injected and unlabeled oocytes was 0.00035 0.0003 puncta/
mm2 (range, 0.0–0.001/mm2; n ¼ 4 oocytes) (Fig. S1 D).
The average puncta density for coinjection of nAChR
b190GGGU mRNA (25 ng/oocyte) and 12.5 ng YFaF-
SACCC-Lys(BODIPYFL) was 0.021 5 0.003/mm
2 (range,
0.015–0.028; n ¼ 5 oocytes). The expected puncta density
was 0.068 puncta/mm2 for this batch (Imax ¼ 3.55 0.2 mA,
n ¼ 4 oocytes) (Fig. 9 B). When these oocytes expressing
nAChR b190Lys(BODIPYFL) receptors were labeled with
aBtxAlexa488 (Fig. S2 C), the puncta density was 0.0455
0.009/mm2 (range, 0.027–0.07/mm2; n ¼ 6 oocytes) (Fig. 9
B). Thus, as expected from the data regarding labeling and
dye photobleaching (Figs. 3 A and 8 A), the di-labeling of
nAChRs revealed receptors that went undetected in experi-
ments incorporating Lys(BODIPFYFL). Control oocytes
from the same batch were injected (as usual) with YFaF-
SACCC-Lys(BODIPYFL) (12.5 ng) (i.e., with tRNA-fUAA
but no mRNA), to assess how unincorporated Lys
(BODIPYFL) contributed to the observed puncta. In these
control oocytes, puncta were detected at a much lower aver-
age density of 0.007 5 0.002/mm2 (range, 0.003–0.014/
mm2; n ¼ 5 oocytes) (Fig. 9 B and Fig. S1 B). When other
similarly injected control oocytes were labeled with aBtxA-
lexa488, we measured a puncta density of 0.004 5 0.002/
mm2 (range, 0.002–0.008/mm2; n ¼ 3 oocytes) (Fig. 9 B
and Fig. S2 D). Another type of control used uninjected oo-
cytes incubated with aBtxAlexa488; the puncta density was
0.003 5 0.002/mm2 (range, 0.0–0.006; n ¼ 3 oocytes)
(Fig. 9 B and Fig. S2 E). Thus, the experimental values were
all internally consistent within a factor of 3.2, which is ac-
ceptable, given the number of assumptions made. Two types
of control yielded much lower puncta densities (Fig. 9 B).
DISCUSSION
We performed imaging of Xenopus oocytes heterologously
expressing nAChR b190Lys(BODIPYFL) in the plasma
membrane. Background signals were minimized by using
Single-Channel Imaging with Lys(BODIPYFL) 235the frameshift-suppressor tRNA (YFaFSACCC) (37,51,52).
The frameshift strategy was crucial, because the more com-
mon nonsense-suppression strategy, using the amber suppres-
sor tRNA (THG73), produced unacceptably high background
signals (data not shown). The b190 site is buried in the resting
state of the receptor (Fig. 1 C), and the efficient incorpora-
tion of Lys(BODIPYFL) demonstrates an advantage over
genetic FP insertions or posttranslational labeling, such as
BODIPYFL-C3-MTS (Fig. 1E) labeling ofb190C,whichwas
not possible. Plasmamembrane imaging of channels incorpo-
rating fUAAs with single-molecule TIRF microscopy may
be considered a technique that extends beyond the incorpora-
tion of fUAAs in receptors and subsequent purification and
reconstitution.
The puncta originating from nAChR b190Lys
(BODIPYFL) were brighter than those puncta from nAChR
geGFP, by an average factor of ~2 (Fig. 5), in agreement
with the known photophysics of BODIPYFL and eGFP in
solution (2,15,36). This is surprising, considering that Lys
(BODIPYFL) is incorporated in the interior of an ion channel
(Fig. 1 C) and interacts with many other amino acids. Also,
labeling with the highly specific fluorescent ligand, aBtxA-
lexa488, allowed us to confirm that nAChR molecules pro-
duced most of the puncta from oocytes expressing nAChR
b190Lys(BODIPYFL) and nAChR geGFP receptors (Figs. 7
and 8). The aBtxAlexa488 studies suggest that ~47% of the
predicted Lys(BODIPYFL) are detected. Thus, similar to FPs
(65,66) and quantum dots (67), there is a nonfluorescent
fraction of molecules, but there are partially different reasons
for each fluorophore. Dye photobleaching during synthesis,
handling, expression, and focusing of a subset of nAChR
b190Lys(BODIPYFL) are the primary reasons for the
dark nAChR fraction. Although our data on aBtxAlexa488
labeling might be limited by impurities in the commercial
aBtxAlexa488, the resolved multistep photobleaching was
consistent with the known 2:1 aBtxAlexa488/nAChR stoichi-
ometry (59).
In general, the single-molecule labeling schemes based on
genetically encoding (fUAA and eGFP) yield a ratio, (puncta
density)/(receptor density expected from electrophysiology),
between 0.5 and 2. The experiments with the tightly bound
ligand, aBtxAlexa488, gave a ratio of 3–4. We consider
this agreement quite satisfactory, considering the numerous
assumptions 1–6 (above in Fluorescent Puncta Density and
Current Density Analysis). The measured ratio would be
changed in unknown directions by variable adherence. Al-
though the puncta density differed between mono-labeled
and di-labeled receptors because of photobleaching, many
viable single fluorophores were still present, enabling paral-
lel single-molecule measurements.
An important advantage of small-molecule fluorophores is
that they are less likely than fluorescent proteins to perturb
protein structure, function, and trafficking (see comparison
of FP size in Fig. 1 A compared with Lys(BODIPYFL) in
Fig. 1 B). This study describes a methodology to incorporatesmall-molecule fluorophores directly into nascent proteins,
using UAA incorporation technology, and allows for the de-
tection of single-membrane proteins in live cellular mem-
branes. Site-specific and single-step fUAA incorporation
will facilitate investigations of many membrane proteins,
but are particularly useful in measuring the gating dynamics,
colocalization, and trafficking in ion channels, because these
channels provide complementary single-molecule measure-
ments of function. The incorporation of fUAAs is particu-
larly important for sites within a-helices (Fig. 1 D) and
within other structural motifs that may not tolerate the large
perturbation of fluorescent proteins (Fig. 1 A).
Finally, although the focus of our report is live-cell imag-
ing, recent reports describe the super-resolution microscopy
of fixed cells (45,68). The localization of fluorescent mole-
cules with ~2-nm resolution was reported. The resolution
of single molecules is dependent on dye brightness (69). In
addition, it was proposed that the power of super-resolution
microcopy will be significantly enhanced with genetically
encoded synthetic dyes into proteins (70). The puncta origi-
nating from nAChR b190Lys(BODIPYFL) were brighter
than those puncta from nAChR geGFP, by an average factor
of ~2 (Fig. 5). Thus, Lys(BODIPYFL) is an attractive alter-
native to FPs for fixed-cell super-resolution microscopy.
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